PBIO News and Press, Pressure BioSciences Inc From 01/11/24

Strategic Merger Combines Uncle Bud’s Globally-Recognized Brand of 70 Products and 865K Member On-Line Community with PBIO’s Strong Scientific Capabilities, Technology Platforms, and Patent Estate Toni Braxton - Multiple Grammy Award Winner and Long-Time Uncle Bud’...

Artificial Intelligence/Machine Learning Also Expected to Significantly Accelerate Advancements in PBIO's Patented, Innovative, and Enabling UltraShear Processing Platform SOUTH EASTON, MA / ACCESSWIRE / January 4, 2024 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a l...

Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced a powerful visionary article in the respected industry tr...

Beyond Formidable Enhancements for the Food and Beverage Industry, UST Offers Promising Applications in Drug Delivery, Cosmetics, Biotechnology, Agriculture, and Advanced Nanomaterials SOUTH EASTON, MA / ACCESSWIRE / December 21, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the ...

Pressure BioSciences (OTCQB: PBIO) , a leading developer and provider of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including food and beverage, health and wellness, nutraceuticals, cosmetics, biothera...

Novel Results Published in Respected Peer-Reviewed Food Science and Emerging Technologies Journal - Discussions Underway with Beverage Industry Companies SOUTH EASTON, MA / ACCESSWIRE / December 12, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO), a leading developer and provider of broadly e...

Pressure BioSciences (OTCQB: PBIO) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, and other industries. The c...

Initial Revenue Expected to Reach $1.0 Million in Year 1 Increasing to More Than $10 Million in Year 5 of the Agreement. "Valor CBD" Topical Spray Now Available on the VST Website. SOUTH EASTON, MA / ACCCESSWIRE / December 1, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or "Company...

2023-11-22 01:35:05 ET More on Pressure BioSciences Financial information for Pressure BioSciences For further details see: Pressure BioSciences GAAP EPS of -$0.29, revenue of $0.41M

Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty-testing services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmeceuticals, agriculture, and food & beverage industries, i...